- Home
- CTSO vs CLIR Comparison
CTSO vs CLIR Comparison
Compare CTSO & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- CLIR
- Stock Information
- Founded
- CTSO 1997
- CLIR 2008
- Country
- CTSO United States
- CLIR United States
- Employees
- CTSO N/A
- CLIR N/A
- Industry
- CTSO Medical/Dental Instruments
- CLIR Industrial Machinery/Components
- Sector
- CTSO Health Care
- CLIR Industrials
- Exchange
- CTSO Nasdaq
- CLIR Nasdaq
- Market Cap
- CTSO 61.3M
- CLIR 59.3M
- IPO Year
- CTSO N/A
- CLIR 2012
- Fundamental
- Price
- CTSO $1.03
- CLIR $0.58
- Analyst Decision
- CTSO Strong Buy
- CLIR Strong Buy
- Analyst Count
- CTSO 3
- CLIR 1
- Target Price
- CTSO $4.67
- CLIR $2.00
- AVG Volume (30 Days)
- CTSO 74.6K
- CLIR 94.7K
- Earning Date
- CTSO 05-08-2025
- CLIR 05-15-2025
- Dividend Yield
- CTSO N/A
- CLIR N/A
- EPS Growth
- CTSO N/A
- CLIR N/A
- EPS
- CTSO N/A
- CLIR N/A
- Revenue
- CTSO $35,594,520.00
- CLIR $3,596,000.00
- Revenue This Year
- CTSO $18.72
- CLIR $511.29
- Revenue Next Year
- CTSO $19.75
- CLIR $117.08
- P/E Ratio
- CTSO N/A
- CLIR N/A
- Revenue Growth
- CTSO 14.51
- CLIR 49.65
- 52 Week Low
- CTSO $0.70
- CLIR $0.46
- 52 Week High
- CTSO $1.61
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- CTSO 53.19
- CLIR 40.05
- Support Level
- CTSO $0.93
- CLIR $0.54
- Resistance Level
- CTSO $1.07
- CLIR $0.62
- Average True Range (ATR)
- CTSO 0.06
- CLIR 0.07
- MACD
- CTSO 0.01
- CLIR 0.00
- Stochastic Oscillator
- CTSO 71.43
- CLIR 37.50
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.